SG Americas Securities
TECX

SG Americas Securities’s Tectonic Therapeutic TECX Stock Holding History

SG Americas Securities’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-871
Closed -$40K – 3526
2021
Q4 		$40K Sell
871
-1,340
-61% -$77K ﹤0.01% 3214
2021
Q3 		$148K Buy
+2,211
New +$181K ﹤0.01% 3448
2021
Q2 		– Sell
-673
Closed -$102K – 3294
2021
Q1 		$102K Buy
+673
New +$109K ﹤0.01% 3078
2020
Q3 		– Sell
-845
Closed -$177K – 3548
2020
Q2 		$177K Buy
845
+254
+43% +$52.3K ﹤0.01% 2959
2020
Q1 		$110K Buy
+591
New +$139K ﹤0.01% 2930

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SG Americas Securities's TECX Position: Q1 2022 in Review

SG Americas Securities sold out of Tectonic Therapeutic (TECX) in Q1 2022, closing a stake of 871 shares — an estimated $40K sold.

SG Americas Securities first reported a position in TECX in Q1 2020 and held it in 5 quarters. The position peaked at $177K in Q2 2020. 79 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

  • SG Americas Securities reported no remaining Tectonic Therapeutic position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 871 Tectonic Therapeutic shares in Q1 2022, an estimated $40K.
  • SG Americas Securities first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 5 quarters.
  • SG Americas Securities's Tectonic Therapeutic position peaked at $177K in Q2 2020.
  • 79 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.